"In vivo is the big win here. If we can demonstrate that in vivo delivery works safely and effectively—as early trials such as Interius in Australia are beginning to show—it could open up a new era.”
Abi Pinchbeck (Editor, Cell & Gene Therapy Insights) speaks with Semih Tareen (Independent Consultant) about the evolving landscape of viral and non-viral delivery, AI’s role in advancing gene therapy, and the future of in vivo engineering.
